(Total Views: 94)
Posted On: 03/30/2021 10:14:55 AM
Post# of 109172

$CURR News! CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://eresearch.fidelity.com/eresearch/eval...2&sb=1

